We report a novel approach for synthesizing LuPO4–apoferritin core–shell nanoparticles based on an apoferritin template. To prepare the nanoparticle, we used non-radioactive lutetium as a model target or surrogate for radiolutetium (177Lu). The central cavity, multi-channel structure, and chemical properties of apoferritin are well-suited for sequentially diffusing lutetium and phosphate ions into the cavity, resulting in a stable core–shell composite. We characterized the synthesized LuPO4–apoferritin nanoparticle using transmission electron microscopy (TEM) and X-ray photoelectron spectroscopy (XPS). We found that LuPO4 formed inside the cavity of apoferritin with an 8 nm diameter. We tested the pre-targeting capability of biotin-modified lutetium–apoferritin nanoparticle using streptavidin-modified magnetic beads and streptavidin-modified fluorescein isothiocyanate (FITC) tracer. This paper presents a simple, fast, and efficient method for synthesizing LuPO4–apoferritin nanoparticle for potential applications in radioimmunotherapy and radioimmunoimaging of cancer.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: